These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28930482)

  • 21. Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia.
    Kawamoto S; Yamamoto K; Toyoda M; Yakushijin K; Matsuoka H; Minami H
    Int J Hematol; 2017 Feb; 105(2):226-229. PubMed ID: 27686674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review.
    Manda-Mapalo MT; Khalili P; Quintana D; Rabinowitz I; Zhang QY
    Cancer Genet; 2016 Oct; 209(10):481-485. PubMed ID: 27810077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents.
    Millot F; Dupraz C; Guilhot J; Suttorp M; Brizard F; Leblanc T; Güneş AM; Sedlacek P; De Bont E; Li CK; Kalwak K; Lausen B; Culic S; Dworzak M; Kaiserova E; De Moerloose B; Roula F; Biondi A; Baruchel A; Guilhot F
    Cancer; 2017 Sep; 123(18):3609-3616. PubMed ID: 28497898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescent in situ hybridization in the diagnosis, prognosis, and treatment monitoring of chronic myeloid leukemia.
    Landstrom AP; Tefferi A
    Leuk Lymphoma; 2006 Mar; 47(3):397-402. PubMed ID: 16396761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
    Pan J; Xue Y; Qiu H; Chen S; Zhang J; Wu Y; Shen J; Wang Y
    Cancer Genet Cytogenet; 2010 Dec; 203(2):333-40. PubMed ID: 21156255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of deletion of derivative chromosome 9 in patients with Ph+ chronic myeloid leukemia].
    Wu W; Xue YQ; Wu YF; Pan JL; Shen J
    Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):183-6. PubMed ID: 16792921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetics in the management of "chronic myeloid leukemia": an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Roche-Lestienne C; Boudry-Labis E; Mozziconacci MJ
    Ann Biol Clin (Paris); 2016 Oct; 74(5):511-515. PubMed ID: 27477825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression.
    Barbouti A; Johansson B; Höglund M; Mauritzson N; Strömbeck B; Nilsson PG; Tanke HJ; Hagemeijer A; Mitelman F; Fioretos T
    Genes Chromosomes Cancer; 2002 Oct; 35(2):127-37. PubMed ID: 12203776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.
    Fabarius A; Leitner A; Hochhaus A; Müller MC; Hanfstein B; Haferlach C; Göhring G; Schlegelberger B; Jotterand M; Reiter A; Jung-Munkwitz S; Proetel U; Schwaab J; Hofmann WK; Schubert J; Einsele H; Ho AD; Falge C; Kanz L; Neubauer A; Kneba M; Stegelmann F; Pfreundschuh M; Waller CF; Spiekermann K; Baerlocher GM; Lauseker M; Pfirrmann M; Hasford J; Saussele S; Hehlmann R;
    Blood; 2011 Dec; 118(26):6760-8. PubMed ID: 22039253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of minimal residual disease in patients with chronic myeloid leukaemia on IFN-alpha 2b therapy using conventional cytogenetics and fluorescence in situ hybridization.
    Talwar R; Choudhry VP; Jobanputra V; Kucheria K
    Natl Med J India; 2002; 15(4):195-8. PubMed ID: 12296472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evolvement of a five-way translocation t(5;9;22;6;17) from a four-way Philadelphia translocation t(5;9;22;6) in a rare case of chronic myeloid leukemia].
    Kong S; Gu Y; Qin Y; Wang Z; Feng L; Jiang Q; Lai Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Dec; 37(12):1395-1398. PubMed ID: 33306831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiplex fluorescence in situ hybridization and cross species color banding of a case of chronic myeloid leukemia in blastic crisis with a complex Philadelphia translocation.
    Harrison CJ; Gibbons B; Yang F; Butler T; Cheung KL; Kearney L; Dirscherl L; Bray-Ward P; Gregson M; Ferguson-Smith M
    Cancer Genet Cytogenet; 2000 Jan; 116(2):105-10. PubMed ID: 10640141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
    Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
    Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complex cytogenetic abnormalities in chronic myeloid leukemia resulting in early progression to blast crisis: a case report.
    Malakzai HA; Rahmani S; Haidary AM; Noor S; Ahmad M; Ibrahimkhil AS; Sharif S
    J Med Case Rep; 2020 Nov; 14(1):231. PubMed ID: 33243265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
    Reid AG; Tarpey PS; Nacheva EP
    Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
    Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The morphological, immunophenotypical and cytogenetic characteristics study of blast crisis in chronic myeloid leukemia].
    Tang X; Wu D; Xue Y; Zhu M; Lu D; Ruan C
    Zhonghua Nei Ke Za Zhi; 2002 Oct; 41(10):685-7. PubMed ID: 12485536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
    Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W
    Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy.
    Lange T; Bumm T; Otto S; Al-Ali HK; Kovacs I; Krug D; Köhler T; Krahl R; Niederwieser D; Deininger MW
    Haematologica; 2004 Jan; 89(1):49-57. PubMed ID: 14754606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.
    Fabarius A; Kalmanti L; Dietz CT; Lauseker M; Rinaldetti S; Haferlach C; Göhring G; Schlegelberger B; Jotterand M; Hanfstein B; Seifarth W; Hänel M; Köhne CH; Lindemann HW; Berdel WE; Staib P; Müller MC; Proetel U; Balleisen L; Goebeler ME; Dengler J; Falge C; Kanz L; Burchert A; Kneba M; Stegelmann F; Pfreundschuh M; Waller CF; Spiekermann K; Brümmendorf TH; Edinger M; Hofmann WK; Pfirrmann M; Hasford J; Krause S; Hochhaus A; Saußele S; Hehlmann R;
    Ann Hematol; 2015 Dec; 94(12):2015-24. PubMed ID: 26385387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.